Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide

HIGHLIGHTS

• who: Caryn E. Plummer from the DepartmentUniversity of have published the Article: Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide, in the Journal: Scientific Reports Scientific Reports
• what: The horses of varied breed (appaloosa, quarter horse, miniature, and paint- aged 5-21) enrolled in the trial, presenting with acute or insidious disease, were admitted into the University of Florida Veterinary Hospital for 4-7 days to begin treatments with topical SOCS1 KIR. Although a pilot study, with limitations to be discussed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.